Genetic testing plays a vital role in diagnosing and treating hematologic malignancies. It enables precise disease classification, prognostic stratification, and personalized treatment planning, guiding targeted therapies and minimizing adverse reactions. By detecting gene mutations and monitoring minimal residual disease (MRD), it helps assess relapse risks and improve patient outcomes.

MedTourChina Joins the YRD International Medical and Special Services Alliance! Exciting milestone! MedTourChina has officially joined the Yangtze River Delta (YRD) International Medical and Special Services Alliance. By integrating with top-tier healthcare resources across Shanghai and Hangzhou, we are further strengthening our ability to provide world-class, seamless medical services to international patients—from cross-border coordination to direct billing.

Unlike CAR-T therapy which is mainly concentrated in hematologic malignancies, NK cell therapy has broader application scenarios. It not only shows good prospects in the treatment of solid tumors such as lung cancer, liver cancer and colorectal cancer, but also has potential value in autoimmune diseases, neurological diseases and other fields, making up for the shortcomings of existing treatment methods.